Skip to main content
SpringerLink
Log in

The perspective of the International Osteoporosis Foundation on the official positions of the International Society for Clinical Densitometry

  • Position Paper
  • Published:
Osteoporosis International Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Lieb E, Lewiecki EM, Binkley N, Hamdy RC (2004) Official positions of the International Society for Clinical Densitometry. J Clin Densitometry 7:1–5

    Google Scholar 

  2. Lewiecki EM, Watts NB, McClung MR, et al for the International Society for Clinical Densitometry (2004) Official position of the International Society for Clinical Densitometry. J Clin Endocrinol Metab 89:3651–3655

    Article  CAS  PubMed  Google Scholar 

  3. Lewiecki EM, Kandler DL, Kiebzak GM, Schmeer P, Prince RL, El Hajj Fuleihan G, Hans D (2004) Special report on the official positions of the International Society for Clinical Densitometry. Osteoporos Int 15:779–784

    Google Scholar 

  4. Writing Group for the ISCD Position Development Conference (2004) Indications and reporting for dual energy X-ray absorptiometry. J Clin Densitometry 7:37–44

    Google Scholar 

  5. National Osteoporosis Foundation (2003) Physicians’ guide to prevention and treatment of osteoporosis. NOF, Washington DC

  6. US Preventive Services Task Force (2002) Screening for osteoporosis in postmenopausal women: recommendations and rationale. Ann Intern Med 137:526–528

    PubMed  Google Scholar 

  7. European Community (1998) Report on osteoporosis in the European Community. EC, Strasbourg

  8. World Health Organisation (1994) Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. Technical Report Series 843. WHO, Geneva

  9. Royal College of Physicians (1999) Osteoporosis: clinical guidelines for the prevention and treatment. RCP, London

  10. Pitt FA, Lloyd-Jones M, Brazier JE, McGrother CW, Kanis JA, Wallace WA, et al (1990) The costs and benefits of screening for and preventing osteoporosis in Trent Region: a report of the Trent Regional Osteoporosis Working Party. Trent Health, UK

    Google Scholar 

  11. Hailey D, Sampietro-Colon L, Marshall D, Rico R, Granados A, Ausna J, Sheldon T (1996) INAHTA project on the effectiveness of bone density measurement and associated treatments for prevention of fractures. International Network of Agencies for Health Technology Assessment. Alberta Heritage Foundation for Medical Research, Edmonton, Alberta

  12. Marshall D, Johnell O, Wedel H (1996) Meta-analysis of how well measures of bone mineral density predict occurrence of osteoporotic fractures. Br Med J 312:1254–1259

    CAS  Google Scholar 

  13. Stone KL, Seeley DG, Lui LY, et al (2003) BMD at multiple sites and risk of fracture of multiple types: long-term results from the study of osteoporotic fractures. J Bone Miner Res 18:1947–1954

    PubMed  Google Scholar 

  14. Siris E, Miller P, Barrett-Connor E, Faulkner K, Welvien L, Abbot T, Berger M, Santora A, Sherwood L (2001) Identification and fracture outcomes of undiagnosed low bone mineral density in postmenopausal women. Results from the National Osteoporosis Risk Assessment. JAMA 286:2815–2822

    Article  CAS  PubMed  Google Scholar 

  15. Schnit SC, van der Klift M, Weel AE, de Laet CE, Burger H, Seeman E, Hofman A, Uitterlinden AG, van Leeuwen JP, Pols HA (2004) Fracture incidence and association with bone density in elderly men and women: the Rotterdam Study. Bone 34:195–202

    Article  CAS  PubMed  Google Scholar 

  16. Rose G (1992) The strategy of preventive medicine. Chapter 4. Prevention for individuals and the ‘high’ risk strategy. Oxford University Press, London, pp 29–52

  17. Kanis JA, Johnell O, Oden A, De Laet C, Jonsson B, Dawson A (2002) Ten year risk of osteoporotic fracture and the effect of risk factors on screening strategies. Bone 30:251–258

    Article  CAS  PubMed  Google Scholar 

  18. World Health Organization (2004) World health report: changing history. WHO, Geneva

    Google Scholar 

  19. Melton LJ III, Johnell O, Lau E, Mautalen CA, Seeman E (2004) Osteoporosis and the global competition for health care resources. J Bone Miner Res 19:1055–1058

    Google Scholar 

  20. Bacon WE, Maggi S, Looker A, Harris T, Navi CR, Giaconi J, et al (1996) International comparison of hip fracture rates in 1988–1989. Osteoporos Int 6; 69–75

    Google Scholar 

  21. Ellfors L, Allander E. Kanis JA et al (1994) The variable incidence of hip fracture in Southern Europe, the MEDOS Study. Osteoporos Int 4:253–263

    CAS  PubMed  Google Scholar 

  22. Johnell O, Gullberg B, Allander E, Kanis JA (1992) The apparent incidence of hip fracture in Europe: A study of national register sources. MEDOS Study Group. Osteoporos Int 2:298–302

    CAS  PubMed  Google Scholar 

  23. Kanis JA, Johnell O, De Laet C, Jonsson B, Oden A, Ogelsby AK (2002) International variations in hip fracture probabilities. Implications for risk assessment. J Bone Miner Res 17:1237–1244

    PubMed  Google Scholar 

  24. Kanis JA, Black D, Cooper C, Dargent P, Dawson-Hughes B, De Laet C, et al (2002) A new approach to the development of assessment guidelines for osteoporosis. Osteoporosis Int 13:527–536

    Article  CAS  Google Scholar 

  25. Kanis JA, Glüer CC for the Committee of Scientific Advisors, International Osteoporosis Foundation (2000) An update on the diagnosis and assessment of osteoporosis with densitometry. Osteoporosis Int 11:192–202

    Article  CAS  Google Scholar 

  26. Johnell O, Kanis JA, Oden A, Johansson H, De Laet C, Delmas PD, et al (2004) Predictive value of bone mineral density for hip and other fractures. J Bone Miner Res (in press)

  27. Looker AC, Orwoll ES, Johnston CC, Lindsay RL, Wahner HW, Dunn WL, et al (1997) Prevalence of low femoral bone density in older US adults from NHANES III. J Bone Miner Res 12:1761–1768

    CAS  PubMed  Google Scholar 

  28. Looker AC, Wahner HW, Dunn WL, Calvo MS, Harris TB, Heyse SP (1998) Updated data on proximal femur bone mineral levels of US adults. Osteoporos Int 8:468–486

    Article  CAS  PubMed  Google Scholar 

  29. Kanis JA, Johnell O, Oden A, Johansson H, Eisman JA, Fujiwara S, Kroger H, Melton III LJ, O’Neill T, Reeve J, Silman A, Tenenhouse A (in press) Why measure femoral neck and lumbar spine BMD for diagnosing osteoporosis. Osteoporos Int

  30. Blake GM, Patel R, Knapp KM, Fogelman I (2003) Does the combination of two BMD measurements improve fracture discrimination? J Bone Miner Res 18:1955–1963

    PubMed  Google Scholar 

  31. Kanis JA, Barton I, Johnell O (2004) Risedronate decreases fracture risk in patients selected solely on the basis of prior vertebral fracture. Osteoporos Int (in press)

  32. Wasnich RD, Davis JW, Ross PD (1994) Spine fracture risk is predicted by non spine fractures. Osteoporos Int 4:1–5

    Google Scholar 

  33. Lunt M, Felsenberg D, Reeve J, Benevolenskaya L, Cannata J, Dequeker J (1997b) Bone density variation and its effects on risk of vertebral deformity in men and women studied in 13 European centres: The EVOS study. J Bone Miner Res 12:1883–1894

    CAS  PubMed  Google Scholar 

  34. DeLaet CEDH, Van Hout BA, Burger H, Hofman A, Weel AEAM, Pols HAP (1998) Hip fracture prediction in elderly men and women: validation in the Rotterdam Study. J Bone Miner Res 13:1587–1593

    PubMed  Google Scholar 

  35. Kanis JA, Johnell O, Oden A, De Laet C, Mellstrom D (2001) Diagnosis of osteoporosis and fracture threshold in men. Calcified Tissue Int 69:218–221

    Google Scholar 

  36. Hui SL, Slemenda CW, Johnston CC (1998) Age and bone mass predictors of fracture in a prospective study. J Clin Invest 81:1804–1809

    Google Scholar 

  37. Kanis JA, Johnell O, Oden A, Dawson A, De Laet C, Jonsson B (2001) Ten year probabilities of osteoporotic fractures according to BMD and diagnostic thresholds. Osteoporosis Int 12:989–995

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. WHO Collaborating Centre for Metabolic Bone Diseases, University of Sheffield, S10 2DU, Sheffield, UK

    John A. Kanis

  2. Endocrine Unit, Austin Hospital, University of Melbourne, Melbourne, Austra;ia

    Ego Seeman

  3. Department of Orthopaedics, Malmo General Hospital, Malmo, Sweden

    Olof Johnell

  4. Department of Internal Medicine, University Hospital, Geneva, Switzerland

    Rene Rizzoli

  5. INSERM Research Unit 403, Hopital Edouard Herriot, Lyon, France

    Pierre Delmas

Authors
  1. John A. Kanis
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ego Seeman
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Olof Johnell
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Rene Rizzoli
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Pierre Delmas
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to John A. Kanis.

Additional information

The authors represent the Committee of Scientific Advisors of the International Osteoporosis Foundation

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kanis, J.A., Seeman, E., Johnell, O. et al. The perspective of the International Osteoporosis Foundation on the official positions of the International Society for Clinical Densitometry. Osteoporos Int 16, 456–459 (2005). https://doi.org/10.1007/s00198-005-1861-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00198-005-1861-0

Keywords

Search

Navigation